Most supply savings programs stop at the contract, and the opportunity that remains sits in clinical detail no spend report captures.
Two physicians perform the same procedure and consume different supplies at different cost. Reimbursement does not match. Multiply that across a procedural portfolio and financial performance is being shaped by decisions no one is measuring.
Procedure- and physician-level data closes that distance. On September 30, Ian O’Malley, executive director of strategic sourcing at University of Chicago Medicine, joins Allen Passerallo to show what that level of detail makes visible: unwarranted clinical variation, the distance between supply cost and reimbursement, and the evidence needed to defend robotics investments and vendor decisions with real-world examples.
Learnings include:
- Identify how procedural variation and supply utilization affect clinical margins
- Use physician- and procedure-level data to uncover cost outliers and savings opportunities
- Evaluate the relationship between supply costs, reimbursement, quality and patient outcomes
- Apply data-driven insights to robotics investments, vendor decisions and clinical supply chain optimization